Introduction Anti-Müllerian hormone (AMH) level has long been considered as a serum
biomarker of ovarian reserve clinically, while emerging data suggest that serum AMH level …

OBJECTIVE: The goal of this work is to expand the usefulness of antimüllerian hormone
(AMH) in predicting in vitro fertilization cycle outcome by demonstrating that AMH …

OBJECTIVE: To discuss, on the basis of the experience of two clinical cases and extensive
literature review, the significance of extremely low levels of anti-Müllerian hormone (AMH) …

Abstract STUDY QUESTION Are anti-Müllerian hormone (AMH) levels assessed in women
aged 32–44 associated with risk of incident early natural menopause? SUMMARY …

Purpose To evaluate the role of Anti-mullerian hormone (AMH) in predicting cumulative
pregnancy outcome during in-vitro fertilization (IVF) treatment. Methods Serum AMH levels …

OBJECTIVE: Anti-Müllerian hormone (AMH) has been evaluated by several groups as a
potential novel clinical marker of ovarian reserve. Considering the wide use of AMH …

Background: Serum anti-Müllerian hormone (AMH) level is considered to be a reliable
marker of ovarian reserve. However, there are conflicting reports on the role of AMH level in …

Objective This study aimed to identify a possible correlation between serum levels of anti-
Müllerian hormone (AMH) and oocyte quality, embryo developmental competence, and …

BACKGROUND Anti-Müllerian hormone (AMH) is an established marker of ovarian reserve
and a good predictor of poor or excessive ovarian response after controlled …

Objective Is the AMH level correlated with age and number of mature oocytes retrieved from
stimulated cycles? Methods This descriptive, retrospective, observational study included the …